RSS

drug discovery

CytoReason has entered into a collaboration agreement with Pfizer over its machine learning model for drug discovery. Read more

News

A new strategic collaboration is aiming to reduce the use of animals in research whilst also accelerating the translation of more research models in drug discovery. Read more

News

A two-year strategic research collaboration and licence agreement has been formed between Karolinska Institute spin out, Pelago Bioscience, and Vertex Pharmaceuticals that will focus on the CETSA method. Read more

News

Preclinical stage drug discovery company, CYTOO, and biopharmaceutical company, Pfizer, have announced a research collaboration with the aim of developing a target discovery platform for Duchenne Muscular Dystrophy (DMD). Read more

News

Newly formed drug discovery company, Azeria Therapeutics, has announced that it has successfully raised £4 million in a Series A investment round from the £70 million CRT Pioneer Fund, managed by Sixth Element Capital. Read more

News

Here, Dr Sheuli Porkess, deputy chief scientific officer, Association of the British Pharmaceutical Industry (ABPI), outlines how the pharmaceutical industry takes a substance from molecule to medicine and how the process requires persistence. Read more

Opinion

Ubiquigent — a company focused on enabling and supporting ubiquitin system targeted drug discovery — has been awarded a new grant from Innovate UK. Read more

News

Global drug discovery and development services company, Crown Bioscience, has extended its existing portfolio of humanised drug target models (HuGEMM) to its San Diego facility. Read more

News

According to scientists from the Medical Research Council (MRC) Laboratory of Molecular Biology in Cambridge, UK, a new drug discovery system can be used to target phosphatases (a family of enzymes) that are mostly considered to be ‘undruggable’. Read more

News

A strategic partnership has been formed between Taconic Biosciences and Cyagen Biosciences — both global companies that generate custom genetically engineered rodent models and associated services. Read more

News

Concept Life Sciences — integrated drug discovery, development and analytical services company — has achieved FDA Establishment Identifier (FEI) registration and commissioned an expansion of its services as a result. Read more

News

Integrated solutions provider — Lonza — has announced the launch of a new bioscience website, designed to support the work of scientists across the bioresearch, drug discovery and pharmaceutical manufacturing fields. Read more

Technology

Provider of integrated drug discovery services, BioAscent Discovery, has secured funding worth £1.6 million from Maven Capital Partners, which it will use for growth through its offering of integrated drug discovery and compound management services. Read more

News

Privately held company, Emulate, has secured a $36 million Series C financing round, the funds from which will be used to expand the company’s product suite and commercialisation of its Human Emulation System. Read more

News

PhoreMost, UK-based biopharmaceutical company, has entered into a collaboration with o2h discovery (o2h) — an Anglo-Indian medicinal chemistry company that has in-house capability to take drug discovery programmes to the IND filing stage. Read more

News

Provider of label-free drug discovery solutions, SAMDI Tech, has announced it has received a small business innovation research (SBIR) grant from the National Institutes of Health (NIH)… Read more

News

Artelo Biosciences, a biopharmaceutical company, has entered into a global research and development partnership with India-based integrated discovery-development service provider, Syngene, and UK-based specialist CRO, Aptus Clinical. Read more

News

Funding for a series of ambitious technology projects set to transform drug discovery has been announced by business secretary, Greg Clark. Read more

News

A multi-target strategic collaboration has been formed between drug discovery and development company, Lodo Therapeutics, and Genentech — a member of the Roche Group. Read more

News

Privately-owned drug discovery services company, Domainex, has been included in the annual top 1000 list of Europe’s fastest growing companies, published by the Financial Times. Read more

News